Company / Current Assets
Upstream Bio, Inc. Current Assets History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$351.8M
FY2025
5-year range
$117.0M / $479.2M
FY2023-FY2025
Trend
-26.6%
vs FY2024
Sector context
#146 of 213
Health Care
What the data says
At $352M, Upstream Bio, Inc.'s current assets ranks #146 of 213 in the Health Care sector. Improved from $117M to $352M over the past 2 years.
Based on SEC 10-K filings.
$352M in FY2025.
Improved from $117M to $352M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#146 of 213 in Health CareTop 69% of 213This company $351.8M Sector average $2.5B
▼
-86.1% below sector average
Key checks
Key Insights
- In FY2025, current assets decreased 26.6% year-over-year.
- Ranks #146 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 8.68 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $351.8M | -26.6% |
| FY2024 | $479.2M | +309.6% |
| FY2023 | $117.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026